|
3-Heptyl-4-hydroxy-7-methoxy-2-methylquinoline
|
H1328370-10mg
|
≥99% |
354155-51-4 |
10mg
|
¥ 2200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Hexa-His
|
H1326279-5mg
|
≥99% |
64134-30-1 |
5mg
|
¥ 1100.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Hexa-His
|
H1326279-25mg
|
≥99% |
64134-30-1 |
25mg
|
¥ 3900.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Hexa-His
|
H1326279-1mg
|
≥99% |
64134-30-1 |
1mg
|
¥ 502.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Hexa-His
|
H1326279-10mg
|
≥99% |
64134-30-1 |
10mg
|
¥ 1700.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-Pyrrole-2,5-dione, 3-(4'-bromo-(1,1'-biphenyl)-4-yl)-4-hydroxy-
|
H1324149-5mg
|
≥98% |
77529-42-1 |
5mg
|
¥ 1200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-Pyrrole-2,5-dione, 3-(4'-bromo-(1,1'-biphenyl)-4-yl)-4-hydroxy-
|
H1324149-50mg
|
≥98% |
77529-42-1 |
50mg
|
¥ 5400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-Pyrrole-2,5-dione, 3-(4'-bromo-(1,1'-biphenyl)-4-yl)-4-hydroxy-
|
H1324149-1mg
|
≥98% |
77529-42-1 |
1mg
|
¥ 636.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1H-Pyrrole-2,5-dione, 3-(4'-bromo-(1,1'-biphenyl)-4-yl)-4-hydroxy-
|
H1324149-10mg
|
≥98% |
77529-42-1 |
10mg
|
¥ 1800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2H-Pyran-2-one, 4-methyl-6-phenyl-
|
H1323280-5mg
|
|
4467-30-5 |
5mg
|
¥ 850.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2H-Pyran-2-one, 4-methyl-6-phenyl-
|
H1323280-1mg
|
|
4467-30-5 |
1mg
|
¥ 400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2H-Pyran-2-one, 4-methyl-6-phenyl-
|
H1323280-10mg
|
|
4467-30-5 |
10mg
|
¥ 1400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Hexadecanamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-
|
H1315918-1mg
|
|
69693-13-6 |
1mg
|
¥ 2208.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6H-Cyclopenta[4,5]furo[3,2-d]pyrimidin-2-amine, 7,8-dihydro-4-[3-(methylamino)-1-azetidinyl]-
|
H1313117-1mg
|
≥98% |
1148115-99-4 |
1mg
|
¥ 3760.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3H-Bis(1)benzopyrano(3,4-b:6',5'-e)pyran-7(7aH)-one, 13,13a-dihydro-6,7a-dihydroxy-9,10-dimethoxy-3,3-dimethyl-, (7aR-cis)-
|
H1309811-1mg
|
≥98% |
72458-85-6 |
1mg
|
¥ 4750.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(S,E) - 4 - ((S)-2 - ((叔丁氧基羰基)氨基)-N,3,3-三甲基丁酰胺基)-2
|
H1307994-50mg
|
≥99% |
187345-37-5 |
50mg
|
¥ 3160.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(S,E) - 4 - ((S)-2 - ((叔丁氧基羰基)氨基)-N,3,3-三甲基丁酰胺基)-2
|
H1307994-25mg
|
≥99% |
187345-37-5 |
25mg
|
¥ 2000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(S,E) - 4 - ((S)-2 - ((叔丁氧基羰基)氨基)-N,3,3-三甲基丁酰胺基)-2
|
H1307994-100mg
|
≥99% |
187345-37-5 |
100mg
|
¥ 5200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-Hydroxy-5-[2-(trifluoromethyl)anilino]isothiazole-4-carbonitrile
|
H1307419-5mg
|
≥99% |
287196-91-2 |
5mg
|
¥ 1400.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-Hydroxy-5-[2-(trifluoromethyl)anilino]isothiazole-4-carbonitrile
|
H1307419-25mg
|
≥99% |
287196-91-2 |
25mg
|
¥ 4500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-Hydroxy-5-[2-(trifluoromethyl)anilino]isothiazole-4-carbonitrile
|
H1307419-10mg
|
≥99% |
287196-91-2 |
10mg
|
¥ 2250.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-Hydroxy-6-{[(8-hydroxy-6-sulfonaphthalen-2-yl)carbamoyl]amino}naphthalene-2-sulfonic acid
|
H1306917-1mg
|
|
6266-54-2 |
1mg
|
¥ 2650.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
5-HT3 antagonist 3
|
H1306608-1mg
|
|
120635-47-4 |
1mg
|
¥ 2205.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-Hydroxy-C4-HSL
|
H1298433-5mg
|
≥99% |
1325550-06-8 |
5mg
|
¥ 2500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |